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table. A x2 test for trend (one degree of freedom) was 3-8 for daily
number of cigarettes (one tail, p 0 0 03) and 3-1 1 for total (life-long)
consumption of cigarettes (p  0-04).
The results suggest that exposure to environmental tobacco
smoke may contribute to the cause of COLD. A relative risk of
about 2 among passive smokers is unlikely to be explained in terms
of misclassification of current or past smokers as non-smokers.4 The
lack of a dose-response pattern should not be surprising, given the
multitude of factors (endogenous and exogenous) that may be
involved in the aetiology of COLD. The smoother relative risk
pattern in relation to lifelong cigarette consumption may reflect the
importance of time-weighted exposure to environmental tobacco
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IMMUNISATION OF THE PRETERM BABY
oiK,&mdash;rso iirm gulueiuies exisL lur Liie iiiunuiiisauon 01 preterm
babies against diphtheria, tetanus, and pertussis (DTP), and
poliomyelitis. Practices vary from no correction to full correction for
gestational age and are largely without scientific foundation.1 We
report the preliminary results of a study to assess the response of
preterm infants to immunisation schedules which make no
allowance for prematurity.
Babies born at or before 35 weeks’ gestation were entered into the
study after the parents gave informed written consent. The infants
were randomised to one of three immunisation schedules:
immunisation at 3,4, and 5 months of age (A); at 3, 4, and 5 months
with a booster at 18 months (B); and at 3, 4, and 10 months (C). On
each occasion all infants receive three drops of live oral poliovaccine
(trivalent Sabin type), and 0-5 ml of adsorbed DTP or diphtheria/
tetanus vaccine by intramuscular injection into the lateral aspect of
the upper thigh. Serum for measurement of antibodies was
obtained immediately before the first dose and 1 month after the
third dose. Further samples will be taken at 19 months and 4 years of
age. The study infants have had the wide range of problems
expected in preterm babies.
Diphtheria and tetanus antitoxin concentrations in the sera were
measured by ELISA.2 Human reference sera of known potencies
determined by in-vivo neutralisation tests were included in each
assay. Antibodies to Bordetella pertussis were also measured by
ELISA but with the supernatant from centrifuged sonicated cells of
B pertu$sis strain W28 at a concentration of 8 g protein per 1 as
antigen. A serum pool from normal DTP-vaccinated children was
used as a reference in each assay and given a nominal concentration
of 100 pertussis antibody units (PAU) per ml. Antibodies were
detected using alkaline phosphatase conjugated anti-human
polyvalent immunoglobulins (raised against x, y, and chains).
Antibodies to polioviruses were assayed by a neutralisation method
in cell cultures in microtitre plates.3
Diphtheria and tetanus antitoxin levels, and antibody titres to B
pertussis and polio (strains 1, 2, and 3), have now been measured in
50 infants after the primary course of immunisation (23 group A, 17
group B, and 10 group C). Irrespective of gestational age (mean 31 ’7 
[SD 26] weeks, range 26-35) or immunisation schedule, all babies
achieved adequate levels of immunity. All achieved protective
antibody levels (greater than 0-01 IU/ml) to diphtheria and tetanus,
and showed a significant rise in PAU/ml. Most achieved polio-
antibody titres greater than 1/256 (the lowest titre was 1/8 to type 1
virus). There have been no abnormal local or general reactions to
immunisation so far. No difficulties have been encountered with
intramuscular injections.
Our preliminary results show that the preterm baby can respond
adequately to routine immunisation starting 3 months after birth
and can achieve immunity by 6 months of age, which confirms the
findings of Bernbaum et al.’ Early protection against pertussis is
clearly desirable in a population liable to respiratory problems and
potentially at greater risk of apnoea and secondary pneumonia.
Parental compliance in the immunisation procedure is likely to be
greater with an earlier timing of the first immunisation. We await
the results of future antibody/antitoxin measurements during
childhood in our study groups to determine the persistence of the
induced immunity prior to the pre-school booster. Our early
evidence suggests, however, that there is no need to delay the start of
immunisation in the preterm infant beyond 3 months from the
actual date of birth.
We are grateful to Dr J. W. G. Smith for advice.
Department of Infectious Diseases,
Seacroft Hospital, Leeds S. P. CONWAY
University Department of Paediatrics
and Child Health,
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WHICH TRANSFORMATION FOR NORMALISING
SKINFOLD AND FATNESS DISTRIBUTIONS?
SIR,-Skinfolds, fat-weights, and body weights tend to be
positively skewed in their distributions, suggesting a biological
"floor" to fatness but no ceiling. Such departures from a
bell-shaped curve complicate statistical analysis. Data are often
presented and analysed after transformation, a 10g1o transform being
popular.1-3 However, it is not certain whether loglo transformation
truly normalises such distributions or whether it introduces new
directions of skewness and increased kurtosis.
We have analysed four skinfolds plus body weight at three age
levels for 2635 males and 2885 females. We looked at untransformed
distributions and at distributions transformed in three ways (log1O’
square root, and normalised Z-score4,S). We calculated centiles for
all the 120 (5 x 3 x 2 x 4) distributions and estimated skewness and
kurtosis.6,7 For the Z-score transforms we also compared the results
TABLE I-SKEWNESS AND KURTOSIS OF RAW SCORES AND LOGlO
TRANSFORMED VALUES, ILLUSTRATED FOR ILIAC SKINFOLD IN
MALES AND WEIGHT IN FEMALES





Distributions of iliac skinfold in women aged 20-49.
with theoretical values of Z at the 5th, 15th, 50th, 85th, and 95th
centiles.4 We wanted to find out how well transformations
converted the skinfold and body weight distributions into gaussian
form.
With only one exception, all the untransformed distributions
were positively skewed, with a long tail to the right, as expected.
Skewness exceeded chance expectation (p < 0.01) for 27 of the 30
distributions and kurtosis did so in 21. Untransformed skinfolds
and weight are illustrated in table I and the figure. Logio
transformed skinfolds and weights were also skewed, this time to the
left (negative skewness), and skewness was significant (p < 0.01) in
more than half of the log,,, transformed distributions. Kurtosis was
diminished with the log to transform, though it remained high where
it was high in the raw distributions of skinfold and weight. Table I
and the figure illustrate the conversion from positively skewed
raw-value distributions to negatively skewed distributions after
loglo transformation. The simple square-root transform was only
moderately effective in reducing skewness and kurtosis.
TABLE II-COMPARISON OF ACTUAL AND THEORETICAL
NORMALISED Z-SCORE VALUES FOR ILIAC SKINFOLD
Source: Neter, Wasserman, and Kumer/ table A- 1, for theoretical values.
Normalised Z-scores proved to be an effective transform (table
n). For all 30 skinfold and weight distributions so transformed the
50th percentile was equal to a Z of 0-00. The symmetrical, gaussian
form of the Z-scored distribution of the iliac skinfold in women is
shown in the figure. The popular loglo transform does not
effectively normalise positively skewed distributions of skinfolds
and weight in adolescents or adults while the use of normalised
Z-scores results in distributions that are closely gaussian.
Center for Human Growth,
University of Michigan,
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PASINI’S REGIONAL JEJUNTTIS
SIR,-Professor Rai and colleagues (Oct 31, p 1020) describe an
epidemic regional jejunitis as a new clinical entity. This disease has
been known in Yugloslavia since 1949, and it carries the name
Pasini’s disease. 1-3 Dr Josip Pasini described the disease in southern
Croatia Yugoslavia as a gangrenous, haemorrhagic, and very often
perforating inflammatory segmental disease of the jejunum. The
disease had a regional character and a severe clinical picture, and it
was often fatal. The description of the disease was based on 26
patients treated between 1944 and 1948. Bacteriological,
toxicological, histological, and some experimental studies were
done, but the cause was never found. One speculation was chemicals
used to preserve food sent to Yugoslavia between 1944 and 1949; the
disease was unknown before 1944. The condition was at first
thought to be a modification of Crohn’s disease but the
histopathological picture was completely different, and it was given
a new name. The disease disappeared and the term Pasini’s disease
has seldom been used. Now a very similar (or even the same) disease
has been reported in India. The name of a very talented but
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LFA-1, LFA-3, AND ICAM-1 EXPRESSION IN
BURKITT’S LYMPHOMA
SIR,-Dr Clayberger and colleagues (Sept 5, p 533) report the
absence of cell surface lymphocyte-function-associated antigen 1
(LFA-1) on high-grade lymphomas, especially Burkitt’s lymphoma
(BL). LFA-1 has broad immunological functions.’ It is well
recognised that many Epstein-Barr virus (EBV) positive BL cell
lines are neither recognised nor killed in vitro by virus-specific
cytotoxic T lymphocytes (CTL), while lymphoblastoid cell lines
(LCL) established by EBV infection of the normal peripheral B
cells from the same patients are destroyed by CTL.2 The
non-expression by the tumour cells of viral antigens, targets of
specific CTL, could represent a mechanism of immunological
escape important in the genesis of BL.Z3 Few data are available
concerning immunity against BL not associated with EBV, which
nonetheless represents 85 % of BL in Europe and in the USA.
We have also used fluorescence activated cell sorting (FACS) to
analyse a large panel of BL cell lines, not only for LFA-1 expression
but also for LFA-3 (a protein of 60 kD expressed by leucocytes,
thymic epithelial cells, and dendritic cells4), and for intercellular
adhesion molecule 1 (ICAM-1), which is one of the putative ligands
of LFA-1.5 Of the BL cell lines tested, 13 were associated with EBV
and 10 were not. We found a low expression of all three markers in
the non-EBV associated BL. In contrast, expression of all three
markers was higher in BL associated with EBV (table). All of the 15
non-malignant LCL tested were positive for all three antigens.
Northern blotting done with LFA-1 p-chain cDNA6 showed that
the level of regulation appeared to be transcriptional because no
LFA-1, LFA-3, AND ICAM-1 EXPRESSION ON BURKITT’S LYMPHOMA
(BL) CELL LINES*
*All BL lines were established at IARC, and phenotypes were analysed at early passages of
the cultures BL were scored as negative if fluorescence positivity was less than 5%.
Monoclonal antibodies used against oc-chain and p-cham of LFA-1 were IOT16 and
LFA-54, and against LFA-3 and ICAM-1 were TS2 9 and RRI 1, respectively-
